<table><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Characteristic</th><th align="center" valign="top" rowspan="1" colspan="1">Rearranged <em>TEL</em></th><th align="center" valign="top" rowspan="1" colspan="1">Germline <em>TEL</em></th></tr><tr><th colspan="3" align="center" valign="top" rowspan="1"><hr></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Median age (years)</td><td align="center" valign="top" rowspan="1" colspan="1">4.4 (1.4-19.7)</td><td align="center" valign="top" rowspan="1" colspan="1">5.1 (1.1-21.1)</td></tr><tr><td colspan="3" align="center" valign="top" rowspan="1"><hr></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Age group</td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&nbsp;&nbsp;&nbsp;&nbsp;&lt; 10 years</td><td align="center" valign="top" rowspan="1" colspan="1">222 (29%)</td><td align="center" valign="top" rowspan="1" colspan="1">531 (71%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&nbsp;&nbsp;&nbsp;&nbsp;≥ 10 years</td><td align="center" valign="top" rowspan="1" colspan="1">22 (13%)</td><td align="center" valign="top" rowspan="1" colspan="1">151 (87%)</td></tr><tr><td colspan="3" align="center" valign="top" rowspan="1"><hr></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Median WBC (× 10<sup>9</sup>/L)</td><td align="center" valign="top" rowspan="1" colspan="1">12 (1-219)</td><td align="center" valign="top" rowspan="1" colspan="1">12 (1-848)</td></tr><tr><td colspan="3" align="center" valign="top" rowspan="1"><hr></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">WBC group</td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&nbsp;&nbsp;&nbsp;&nbsp;&lt; 50 × 10<sup>9</sup>/L</td><td align="center" valign="top" rowspan="1" colspan="1">198 (27%)</td><td align="center" valign="top" rowspan="1" colspan="1">549 (73%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&nbsp;&nbsp;&nbsp;&nbsp;≥ 50 × 10<sup>9</sup>/L</td><td align="center" valign="top" rowspan="1" colspan="1">46 (26%)</td><td align="center" valign="top" rowspan="1" colspan="1">133 (74%)</td></tr><tr><td colspan="3" align="center" valign="top" rowspan="1"><hr></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NCI risk group</td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&nbsp;&nbsp;&nbsp;&nbsp;Standard</td><td align="center" valign="top" rowspan="1" colspan="1">178 (29%)</td><td align="center" valign="top" rowspan="1" colspan="1">435 (71%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&nbsp;&nbsp;&nbsp;&nbsp;High</td><td align="center" valign="top" rowspan="1" colspan="1">66 (21%)</td><td align="center" valign="top" rowspan="1" colspan="1">247 (79%)</td></tr><tr><td colspan="3" align="center" valign="top" rowspan="1"><hr></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sex</td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&nbsp;&nbsp;&nbsp;&nbsp;Male</td><td align="center" valign="top" rowspan="1" colspan="1">123 (24%)</td><td align="center" valign="top" rowspan="1" colspan="1">382 (76%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&nbsp;&nbsp;&nbsp;&nbsp;Female</td><td align="center" valign="top" rowspan="1" colspan="1">121 (29%)</td><td align="center" valign="top" rowspan="1" colspan="1">300 (71%)</td></tr><tr><td colspan="3" align="center" valign="top" rowspan="1"><hr></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Race</td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&nbsp;&nbsp;&nbsp;&nbsp;White</td><td align="center" valign="top" rowspan="1" colspan="1">184 (29%)</td><td align="center" valign="top" rowspan="1" colspan="1">447 (71%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&nbsp;&nbsp;&nbsp;&nbsp;Black</td><td align="center" valign="top" rowspan="1" colspan="1">12 (16%)</td><td align="center" valign="top" rowspan="1" colspan="1">62 (84%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&nbsp;&nbsp;&nbsp;&nbsp;Hispanic</td><td align="center" valign="top" rowspan="1" colspan="1">32 (21%)</td><td align="center" valign="top" rowspan="1" colspan="1">124 (79%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&nbsp;&nbsp;&nbsp;&nbsp;Other</td><td align="center" valign="top" rowspan="1" colspan="1">16 (25%)</td><td align="center" valign="top" rowspan="1" colspan="1">49 (75%)</td></tr><tr><td colspan="3" align="center" valign="top" rowspan="1"><hr></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CNS Status</td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&nbsp;&nbsp;&nbsp;&nbsp;Negative</td><td align="center" valign="top" rowspan="1" colspan="1">232 (95.1%)</td><td align="center" valign="top" rowspan="1" colspan="1">586 (86.0%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&nbsp;&nbsp;&nbsp;&nbsp;Positive</td><td align="center" valign="top" rowspan="1" colspan="1">12 (4.9%)</td><td align="center" valign="top" rowspan="1" colspan="1">96 (14.0%)</td></tr><tr><td colspan="3" align="center" valign="top" rowspan="1"><hr></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Day-15 marrow status</td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&nbsp;&nbsp;&nbsp;&nbsp;M1</td><td align="center" valign="top" rowspan="1" colspan="1">214 (27%)</td><td align="center" valign="top" rowspan="1" colspan="1">566 (73%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&nbsp;&nbsp;&nbsp;&nbsp;M2/M3</td><td align="center" valign="top" rowspan="1" colspan="1">14 (18%)</td><td align="center" valign="top" rowspan="1" colspan="1">63 (82%)</td></tr><tr><td colspan="3" align="center" valign="top" rowspan="1"><hr></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Treatment study</td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&nbsp;&nbsp;&nbsp;&nbsp;9201</td><td align="center" valign="top" rowspan="1" colspan="1">7 (5%)</td><td align="center" valign="top" rowspan="1" colspan="1">145 (95%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&nbsp;&nbsp;&nbsp;&nbsp;9605</td><td align="center" valign="top" rowspan="1" colspan="1">173 (37%)</td><td align="center" valign="top" rowspan="1" colspan="1">297 (63%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&nbsp;&nbsp;&nbsp;&nbsp;9406</td><td align="center" valign="top" rowspan="1" colspan="1">64 (21%)</td><td align="center" valign="top" rowspan="1" colspan="1">240 (79%)</td></tr><tr><td colspan="3" align="center" valign="top" rowspan="1"><hr></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Median follow-up (yrs)</td><td align="center" valign="top" rowspan="1" colspan="1">8 (0.0-10.0)</td><td align="center" valign="top" rowspan="1" colspan="1">7.7 (0.0-10.0)</td></tr><tr><td colspan="3" align="center" valign="top" rowspan="1"><hr></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Total</td><td align="center" valign="top" rowspan="1" colspan="1">244 (26%)</td><td align="center" valign="top" rowspan="1" colspan="1">682 (74%)</td></tr></tbody></table>